Shabtay-Orbach Ayelet, Amit Moran, Binenbaum Yoav, Na'ara Shorook, Gil Ziv
The Laboratory for Applied Cancer Research, The Clinical Research Center at Rambam, Haifa, Israel.
Department of Otolaryngology Head and Neck Surgery, Rambam Medical Center, Rapaport School of Medicine, The Technion Israel Institute of Technology, Haifa, Israel.
Int J Cancer. 2015 Sep 1;137(5):1012-20. doi: 10.1002/ijc.29380. Epub 2014 Dec 13.
It was suggested that the brain microenvironment plays a role in glioma progression. Here we investigate the mechanism by which astrocytes which are abundant in glioma tumors, promote cancer cell invasion. In this study, we evaluated the effects of astrocytes on glioma biology both in vitro and in vivo and determined the downstream paracrine effect of glial-derived neurotrophic factor (GDNF) on tumor invasion. Astrocytes-conditioned media (ACM) significantly increased human and murine glioma cells migration compared to controls. This effect was inhibited when the activity of GDNF on glioma cells was blocked by RET-Fc chimera or anti-GDNF Ab and by small interfering RNA directed against GDNF expression by astrocytes. Glioma cells incubated with ACM led to time dependent phosphorylation of the GDNF receptor, RET and downstream activation of AKT. Tumor migration and GDNF-RET-AKT activation was inhibited by the RET small-molecule inhibitor pyrazolopyrimidine-1 (PP1) and by the AKT inhibitor LY294002. Finally, blocking of RET by PP1 or knockout of the RET coreceptor GFRα1 in glioma cells reduced the size of brain tumors in immunocompetent mice. We suggest a mechanism by which astrocytes attracted to the glioma tumors facilitate brain invasion by secretion of GDNF and activation of RET/GFRα1 receptors expressed by the cancer cells.
有人提出脑微环境在胶质瘤进展中起作用。在此,我们研究胶质瘤肿瘤中丰富的星形胶质细胞促进癌细胞侵袭的机制。在本研究中,我们在体外和体内评估了星形胶质细胞对胶质瘤生物学行为的影响,并确定了胶质细胞源性神经营养因子(GDNF)对肿瘤侵袭的下游旁分泌作用。与对照组相比,星形胶质细胞条件培养基(ACM)显著增加了人源和鼠源胶质瘤细胞的迁移。当GDNF对胶质瘤细胞的活性被RET-Fc嵌合体或抗GDNF抗体以及针对星形胶质细胞GDNF表达的小干扰RNA阻断时,这种作用受到抑制。用ACM孵育的胶质瘤细胞导致GDNF受体RET的时间依赖性磷酸化以及AKT的下游激活。RET小分子抑制剂吡唑并嘧啶-1(PP1)和AKT抑制剂LY294002抑制了肿瘤迁移和GDNF-RET-AKT激活。最后,在免疫活性小鼠中,用PP1阻断RET或敲除胶质瘤细胞中的RET共受体GFRα1可减小脑肿瘤的大小。我们提出了一种机制,即被吸引到胶质瘤肿瘤的星形胶质细胞通过分泌GDNF和激活癌细胞表达的RET/GFRα1受体促进脑侵袭。